Tincture October 10, 2019
Drew Smith, PhD

Precision (or personalized) medicine has now reached its ultimate endpoint. Researchers devised a medicine to treat a single patient — a girl with a unique genetic defect that caused her brain cells to accumulate waste and die. The one-off drug created for her seems to have halted disease progression.

It’s an amazing story. And now that we’ve reached this endpoint, perhaps it’s time to step back and take a look at what precision medicine promises and what it has delivered.

We’ve invested a lot of hope and a lot of money in the precision medicine paradigm. President Obama, at the launch of the Precision Medicine Initiative 2015 said that it “…gives us one of the greatest opportunities for new medical...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Payment Models, Precision Medicine, Provider, Technology
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article